论文部分内容阅读
目的:探讨β受体阻滞剂倍他乐克在慢性充血性心力衰竭中的疗效。方法:选择56例慢性充血性心力衰竭住院患者,随机分为治疗组和对照组,治疗组在常规应用强心、利尿、扩血管药物的基础上,加用β受体阻滞剂倍它乐克。结果:治疗3个月后治疗组心力衰竭患者心功能分级显著改善,心率明显降低,收缩压及舒张压也显著降低。结论:在常规抗心力衰竭药物治疗基础上加用β受体阻滞剂可明显改善慢性心力衰竭患者的心功能,提高生活质量,延长患者寿命。
Objective: To investigate the efficacy of β-blocker betametabol in patients with chronic congestive heart failure. Methods: Fifty-six inpatients with chronic congestive heart failure were selected and randomly divided into treatment group and control group. On the basis of conventional cardioplegia, diuretic and vasodilator drugs, the treatment group was given beta-blocker G Results: After 3 months of treatment, the heart function scores of the patients in the treatment group were significantly improved, the heart rate was significantly decreased, and the systolic and diastolic blood pressures were significantly lower. Conclusion: The addition of β-blockers to conventional anti-heart failure drug therapy can significantly improve cardiac function, improve quality of life and prolong patient’s life in patients with chronic heart failure.